AVANTAX ADVISORY SERVICES, INC. - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
AVANTAX ADVISORY SERVICES, INC. ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$379,373
-3.6%
105,970
-0.6%
0.00%0.0%
Q2 2023$393,428
+4.6%
106,620
-6.2%
0.00%
-20.0%
Q1 2023$376,082
-23.8%
113,620
-10.6%
0.01%
-28.6%
Q4 2022$493,226
+59.6%
127,1200.0%0.01%
+40.0%
Q3 2022$309,000
+22.6%
127,1200.0%0.01%
+25.0%
Q2 2022$252,000
+8.2%
127,1200.0%0.00%
+33.3%
Q1 2022$233,000
+30.2%
127,1200.0%0.00%0.0%
Q4 2021$179,000
+121.0%
127,120
+76.3%
0.00%
+200.0%
Q3 2021$81,000
-65.5%
72,120
-50.9%
0.00%
-75.0%
Q2 2021$235,000
-9.6%
146,830
-0.0%
0.00%
-33.3%
Q1 2021$260,000
+18.7%
146,870
+31.3%
0.01%
+20.0%
Q4 2020$219,000
-42.8%
111,870
-29.8%
0.01%
-16.7%
Q3 2020$383,000
-13.9%
159,370
+4.8%
0.01%
-53.8%
Q2 2020$445,000
-10.1%
152,050
-11.6%
0.01%
-13.3%
Q1 2020$495,000
-8.3%
172,050
+27.4%
0.02%
+15.4%
Q4 2019$540,000
-10.1%
135,0500.0%0.01%
-45.8%
Q3 2019$601,000
+14.9%
135,0500.0%0.02%
+4.3%
Q2 2019$523,000
+38.0%
135,050
+35.0%
0.02%
+15.0%
Q1 2019$379,000
+142.9%
100,050
+53.8%
0.02%
-23.1%
Q4 2018$156,00065,0500.03%
Other shareholders
ADMA BIOLOGICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aisling Capital LLC 3,608,171$8,624,0002.44%
Broadfin Capital, LLC 4,226,077$10,100,0001.33%
MORGENS WATERFALL VINTIADIS & CO INC 400,000$956,0000.85%
Consonance Capital Management LP 4,588,352$10,966,0000.81%
Perceptive Advisors 6,521,102$14,542,0000.55%
Diag Capital Management, LP 182,100$435,0000.50%
683 Capital Management, LLC 805,000$1,924,0000.12%
ARDSLEY ADVISORY PARTNERS LP 50,000$120,0000.03%
AVANTAX ADVISORY SERVICES, INC. 65,050$156,0000.03%
PURA VIDA INVESTMENTS, LLC 37,170$89,0000.02%
View complete list of ADMA BIOLOGICS INC shareholders